A vaccine against the killer H5N1 bird flu virus could be licensed for human use in a year, but when to use it is becoming a “tricky issue”, a senior World Health Organisation official said on Wednesday. Full Story
About OODA Analyst
OODA is comprised of a unique team of international experts capable of providing advanced intelligence and analysis, strategy and planning support, risk and threat management, training, decision support, crisis response, and security services to global corporations and governments.